Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Oncogenic mutant of Gα12 stimulates cell proliferation through cycloxygenase-2 signaling pathway

Oncogene volume 18, pages 7185–7189 (1999)Cite this article

Abstract

Expression of the GTPase-deficient, activated mutant α-subunit of the heterotrimeric G protein G12 (Gα12QL) leads to the neoplastic transformation of fibroblast cell lines. The mitogenic pathway regulated by Gα12QL includes an extensive signaling network involving several small GTPases and various kinases. In addition, Gα12QL has been shown to potentiate the serum-induced phospholipase-A2 activity in NIH3T3 cells. In the present study, we demonstrate that cycloxygenase-2 (COX-2) pathway is involved in the mitogenic pathway activated by Gα12QL. Expression of Gα12QL and not Gα13QL, stimulates the serum-induced release of arachidonic acid in NIH3T3 cells. Furthermore, expression of Gα12QL or the stimulation of wild-type Gα12 induces the expression of COX-2. Our results also indicate that the COX-2 inhibitor acutely disrupts the DNA-synthesis stimulated by Gα12QL in NIH3T3 cells. These studies, for the first time, identify the crucial role of COX-2 in Gα12-mediated regulation of cell proliferation and suggest a role for prostaglandin-derived autocrine loop in Gα12-mediated signaling pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aragay AM, Collins LR, Post GR, Watson AJ, Feramisco JR, Brown JH and Simon MI. . 1995 J. Biol. Chem. 270: 20073–20077.

  • Buhl AM, Lassignal-Johnson N, Dhanasekaran N and Johnson GL. . 1995 J. Biol. Chem. 270: 24631–24634.

  • Chan AM-L, Fleming TP, McGovern ES, Chedid M, Miki T and Aaronson SA. . 1993 Mol. Cell. Biol. 13: 762–768.

  • Collins LR, Minden A, Karin M and Brown JH. . 1996 J. Biol. Chem. 271: 17349–17353.

  • Dennis EA. . 1997 Trends Biochem. Sci. 22: 1–2.

  • Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB and Lipsky PE. . 1998 FASEB J. 12: 1063–1073.

  • Dhanasekaran N and Dermott JM. . 1996 Cell Signaling. 8: 235–234.

  • Dhanasekaran N, Tsim S-T, Dermott JM and Onesime D. . 1998 Oncogene 17: 1383–1394.

  • Fromm C, Coso OA, Montaner S, Xu N and Gutkind JS. . 1997 Proc. Natl. Acad. Sci. USA 94: 10098–10103.

  • Gebauer G, Peter AT, Onesime D and Dhanasekaran N. . 1999 J. Cell. Biochem. 75: 547–554.

  • Heasley LE, Thaler S, Nicks M, Price B, Skorecki K and Nemenoff RA. . 1997 J. Biol. Chem. 272: 14501–14504.

  • Herschman HR. . 1994 Cancer Metastasis Rev. 13: 241–256.

  • Hooley R, Yu C-Y, Symons M and Barber DL. . 1996 J. Biol. Chem. 271: 6152–6158.

  • Jiang H, Wu D and Simon MI. . 1993 FEBS Lett. 3: 319–322.

  • Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR. . 1991 J. Biol. Chem. 266: 12866–12872.

  • Leslie CC. . 1997 J. Biol. Chem. 272: 16709–16712.

  • Needham LK and Rozengurt E. . 1998 J. Biol. Chem. 273: 14626–16632.

  • Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY and Isakson PC. . 1997 J. Med. Chem. 40: 1347–1365.

  • Reddy ST and Herschman HR. . 1994 J. Biol. Chem. 269: 15473–15480.

  • Slice LW, Walsh JH and Rozengurt E. . 1999 J. Biol. Chem. 274: 27562–27566.

  • Tolkacheva T, Feuer B, Lorenzi MV, Saez R and Chan AM-L. . 1997 Oncogene 15: 727–735.

  • Tsujii M, Kawano S and DuBois RN. . 1997 Proc. Natl. Acad. Sci. USA 94: 3336–3340.

  • Vane JR, Bakhle YS and Botting RM. . 1998 Annu. Rev. Pharmacol. Toxicol. 38: 97–120.

  • Vara Prasad MVVS, Dermott JM, Heasley LE, Johnson GL and Dhanasekaran N. . (1995) J. Biol. Chem. 270: 18655–18659.

  • Vara Prasad M, Shore SK and Dhanasekaran N. . 1994 Oncogene 9: 2425–2429.

  • Voyno-Yasenetskaya TA, Faure MP, Ahn NG and Bourne HR. . 1996 J. Biol. Chem. 271: 21081–21087.

  • Voyno-Yasenetskaya T, Pace AM and Bourne HR. . 1994 Oncogene 9: 2559–2565.

  • Xu N, Bradley L, Ambudkar I and Gutkind JS. . 1993 Proc. Natl. Acad. Sci. USA 90: 11354–11358.

  • Xu N, Voyno-Yasenetskaya T and Gutkind JS. . 1994 Biochem, Biophys. Res. Comm. 201: 603–609.

  • Zhang Y, Saez R, Leal MA and Chan AM-L. . 1996 Oncogene 12: 2377–2383.

Download references

Acknowledgements

This work was supported by National Institutes of Health Grant GM 49897 (N Dhanasekaran).

Author information

Authors and Affiliations

  1. Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, 19140, Pennsylvania, PA, USA

    Jonathan M Dermott, MV Ramana Reddy, Djamila Onesime, E Premkumar Reddy & N Dhanasekaran

Authors
  1. Jonathan M Dermott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MV Ramana Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Djamila Onesime
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Premkumar Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Dhanasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dermott, J., Reddy, M., Onesime, D. et al. Oncogenic mutant of Gα12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene 18, 7185–7189 (1999). https://doi.org/10.1038/sj.onc.1203345

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203345

Keywords

This article is cited by

Search

Advanced search

Quick links